Charcot-Marie-Tooth Disease Associated With a Novel Mutation in MFN2 Presenting With Subacute Vision Loss

被引：0
|
作者：
Li, Yafeng [1 ]
Aleman, Tomas S. [1 ]
Quinn, Colin C. [2 ]
Xia, Tian [1 ]
Miller, Charles G. [1 ]
Kim, Benjamin J. [1 ]
Tamhankar, Madhura A. [1 ]
机构：
[1] Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Dept Neurol, Philadelphia, PA USA
来源：
JOURNAL OF NEURO-OPHTHALMOLOGY | 2022年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E381 / E384
页数：4
相关论文
共 50 条
  • [21] A novel double mutation in cis in MFN2 causes Charcot–Marie–Tooth neuropathy type 2A
    Su-Yeon Park
    So Yeon Kim
    Yoon-Ho Hong
    Sung Im Cho
    Moon-Woo Seong
    Sung Sup Park
    neurogenetics, 2012, 13 : 275 - 280
  • [22] Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease
    Nan, Haitian
    Takaki, Ryusuke
    Hata, Takanori
    Ichinose, Yuta
    Tsuchiya, Mai
    Koh, Kishin
    Takiyama, Yoshihisa
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 (01) : 156 - 160
  • [23] Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease
    Kostera-Pruszczyk, Anna
    Kosinska, Joanna
    Pollak, Agnieszka
    Stawinski, Piotr
    Walczak, Anna
    Wasilewska, Krystyna
    Potulska-Chromik, Anna
    Szczudlik, Piotr
    Kaminska, Anna
    Ploski, Rafal
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (03) : 242 - 245
  • [24] Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous:: Families with and without MFN2 mutations
    Zhu, D
    Kennerson, ML
    Walizada, G
    Zücher, S
    Vance, JM
    Nicholson, GA
    NEUROLOGY, 2005, 65 (03) : 496 - 497
  • [25] Novel MFN2,BSCL2 and LRSAM1 variants in a cohort of Chinese patients with Charcot-Marie-Tooth disease
    孙博
    China Medical Abstracts(Internal Medicine), 2022, 39 (04) : 236 - 236
  • [26] MUTATION IN PNKP PRESENTING INITIALLY AS AXONAL CHARCOT-MARIE-TOOTH DISEASE
    Pedroso, Jose Luiz
    Rocha, Clarissa R. R.
    Macedo-Souza, Lucia I.
    De Mario, Vitor
    Marques, Wilson, Jr.
    Barsottini, Orlando G. P.
    Bulle Oliveira, Acary S.
    Menck, Carlos F. M.
    Kok, Fernando
    NEUROLOGY-GENETICS, 2015, 1 (04)
  • [27] MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A
    Rocha, Agostinho G.
    Franco, Antonietta
    Krezel, Andrzej M.
    Rumsey, Jeanne M.
    Alberti, Justin M.
    Knight, William C.
    Biris, Nikolaos
    Zacharioudakis, Emmanouil
    Janetka, James W.
    Baloh, Robert H.
    Kitsis, Richard N.
    Mochly-Rosen, Daria
    Townsend, R. Reid
    Gavathiotis, Evripidis
    Dorn, Gerald W., II
    SCIENCE, 2018, 360 (6386) : 336 - 341
  • [28] Early onset severe and late onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations
    Choi, Byung-Ok
    Park, Kee-Duk
    Kim, Sang-Beom
    Cho, Phil-Za
    Sunwoo, Il-Nam
    NEUROMUSCULAR DISORDERS, 2006, 16 : S131 - S132
  • [29] A cellular assay to determine the fusion capacity of MFN2 variants linked to Charcot-Marie-Tooth disease of type 2 A
    Barsa, Chloe
    Perrin, Julian
    David, Claudine
    Mourier, Arnaud
    Rojo, Manuel
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [30] AXONAL CHARCOT-MARIE-TOOTH (CMT): MUTATIONS AND POLYMORPHISMS IN THE MITOFUSIN-2 GENE (MFN2)
    Taioli, F.
    Ferrarini, M.
    Cavallaro, T.
    Ferrari, S.
    Fabrizi, G. M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 31 - 31
12345